14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CPRX ranks #11860 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Catalyst Pharmaceuticals Stock Forecast NASDAQ:CPRX

$5.64 (-0.18%)

Volume: 785k

Closed: Jan 25, 2022

Hollow Logo Score: -3.044

Catalyst Pharmaceuticals Stock Forecast

$5.64 (-0.18%)

Volume: 785k

Closed: Jan 25, 2022

Score Hollow Logo -3.044

Catalyst Pharmaceuticals Stock Price (Quote) NASDAQ:CPRX

$5.64 ( -0.18% ) Tuesday, 25th Jan 2022

Range Low Price High Price Comment
30 days $5.29 $7.35 Tuesday, 25th Jan 2022 CPRX stock ended at $5.64. This is 0.18% less than the trading day before Monday, 24th Jan 2022. During the day the stock fluctuated 3.83% from a day low at $5.49 to a day high of $5.70.
90 days $5.29 $7.58
52 weeks $3.27 $7.58

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2022-01-25 $5.57 $5.70 $5.49 $5.64 785 031
2022-01-24 $5.45 $5.68 $5.29 $5.65 1 403 242
2022-01-21 $5.55 $5.74 $5.33 $5.54 1 604 668
2022-01-20 $5.90 $6.00 $5.67 $5.69 724 270
2022-01-19 $5.90 $6.09 $5.86 $5.87 777 352
2022-01-18 $6.15 $6.19 $5.87 $5.88 1 353 123
2022-01-14 $6.09 $6.26 $5.97 $6.24 870 307
2022-01-13 $6.28 $6.44 $6.11 $6.14 834 744
2022-01-12 $6.43 $6.48 $6.21 $6.23 752 942
2022-01-11 $6.37 $6.42 $6.21 $6.38 636 406
2022-01-10 $6.51 $6.51 $6.24 $6.36 957 598
2022-01-07 $6.60 $6.73 $6.49 $6.56 661 110
2022-01-06 $6.51 $6.78 $6.50 $6.60 747 600
2022-01-05 $6.89 $6.93 $6.49 $6.51 883 503
2022-01-04 $6.94 $7.05 $6.72 $6.80 762 799
2022-01-03 $6.79 $6.93 $6.72 $6.92 844 131
2021-12-31 $6.99 $7.01 $6.75 $6.77 653 418
2021-12-30 $7.16 $7.28 $6.87 $6.89 873 803
2021-12-29 $7.05 $7.18 $7.02 $7.17 568 874
2021-12-28 $7.23 $7.35 $7.06 $7.07 714 939
2021-12-27 $7.22 $7.29 $7.13 $7.26 692 474
2021-12-23 $6.99 $7.21 $6.93 $7.18 837 953
2021-12-22 $6.92 $7.08 $6.83 $6.99 1 041 332
2021-12-21 $7.05 $7.05 $6.80 $6.90 1 309 785
2021-12-20 $6.89 $6.95 $6.63 $6.92 1 481 599
2021-12-17 $6.70 $7.19 $6.70 $6.90 4 945 199
2021-12-16 $6.93 $7.00 $6.66 $6.72 1 273 847
2021-12-15 $6.50 $6.93 $6.40 $6.92 1 509 337
2021-12-14 $6.50 $6.57 $6.33 $6.39 1 494 608
2021-12-13 $6.64 $6.68 $6.49 $6.52 1 109 518
2021-12-10 $6.64 $6.72 $6.51 $6.59 927 749
2021-12-09 $6.88 $6.88 $6.55 $6.55 863 720
2021-12-08 $7.11 $7.15 $6.88 $6.91 615 221
2021-12-07 $6.80 $7.16 $6.76 $7.07 1 198 762
2021-12-06 $6.92 $7.00 $6.81 $6.93 742 366
2021-12-03 $7.08 $7.12 $6.79 $6.86 902 748
2021-12-02 $6.82 $7.10 $6.81 $7.06 844 432
2021-12-01 $7.06 $7.27 $6.86 $6.86 944 758
2021-11-30 $6.99 $7.06 $6.84 $7.00 851 874
2021-11-29 $7.09 $7.24 $6.94 $6.96 961 504
2021-11-26 $7.28 $7.42 $7.05 $7.10 720 858
2021-11-24 $7.28 $7.46 $7.18 $7.38 591 504
2021-11-23 $7.20 $7.40 $7.14 $7.30 909 385
2021-11-22 $7.33 $7.46 $7.24 $7.27 933 922
2021-11-19 $7.33 $7.43 $7.23 $7.32 591 171
2021-11-18 $7.38 $7.45 $7.21 $7.30 801 903
2021-11-17 $7.25 $7.47 $7.22 $7.45 1 111 769
2021-11-16 $7.16 $7.31 $6.72 $7.22 1 102 407
2021-11-15 $7.44 $7.51 $7.25 $7.30 882 643
2021-11-12 $7.30 $7.58 $7.26 $7.41 2 110 012

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as w... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT